Russia’s key biomedical technologies forum BIOTECHMED 2018 was held in Gelendzhik on September, 9-11 with the Russian Export Center acting as the general partner of the event.
Medical services and devices export was one of BIOTECHMED 2018 key topics. During the forum its participants discussed the questions of Russia’s pharmaceutical, biotechnological, medical and cosmetics industry enterprises development and realization of their potential.
Russian Export Center JSC (REC) is a State-owned development institute established by the Russian Government to support the development of the non-commodity exports industry/sector. REC acted as an expert during the forum’s programme, occupied a separate pavilion at the exhibition and hosted a press conference. The Center specialists shared the information on the existing export cycle, entrepreneurial activities in exports and external economic activity. According to the Edict of the President of the Russian Federation Vladimir Putin, the Russian enterprises should double the non-resource non-energy export volumes during the next six years. During the Forum REC organized a series of events and meetings dedicated to the questions of the Russian medicine and medical services export.
Irina Kashirina, REC Head of the medical and pharmaceutical industry export support project spoke during the panel “Export cooperation development in biotechnology and biomedicine”. The participants discussed export development measures in the context of cooperation among Russia’s Minpromtorg, REC and the manufacturers, taking into account successful cases. Irina Kashirina also took part in the panel “The strategy of Russia’s cosmetics industry development”. The session included discussion of R&D competences development as well as export potential of Russia’s cosmetics industry.
BIOTECHMED forum also included a press conference with Irina Kashirina, REC Head of the medical and pharmaceutical industry export support project. The press conference touched upon the plan on Russia’s medical and pharmaceutical industry export support measures that are to enter the national project “International cooperation and exports”.
“Russia’s pharmaceutical industry main problem is complexity and high costs of testing on foreign markets in order to obtain international certificates which would allow exporting the products. We are now preparing a set of norms that will allow the companies to more effectively use the financial support measures to pass these tests,” commented Mrs. Kashirina.